The MUC5B Promoter Variant and Autoimmune Associated Interstitial Lung Disease

Authors

Cheilonda Johnson, MD, MHS, Johns Hopkins University School of Medicine Division of Pulmonary and Critical Care Medicine Baltimore, MD 21224

Document Type

Presentation

Publication Date

4-23-2014

Comments

Dr. Johnson is currently a Pulmonary/Critical Care Medicine Fellow at Johns Hopkins University School of Medicine in Baltimore, MD. She received her medical school degree from the University of Pennsylvania, School of Medicine. Postgraduate Training inInternal Medicine Residency was completed at Massachusetts General Hospital in Boston, MA

Research Support

Title: Determinants of Rheumatoid Arthritis Associated Interstitial Lung Disease

Funding Agency: Arthritis Foundation

Date(s): July 2013-June 2015

Total Direct Costs: $50,000/year

Role: Principal Investigator

Awards

ACCP 18^th Pulmonary & Critical Fellows Conference Travel Award 2011

American Thoracic Society Minority Trainee Development Award 2013

ACCP Physician Leadership Development Conference Travel Award 2013

Abstract

Learning Objectives:

1. Understand the epidemiology of myositis-Interstitial Lung Disease.

2. Appreciate the importance of myositis specific autoantibodies.

3. Review known genetic risk factors for myositis-Interstitial Lung Disease.

Presentation: 30 minutes (turn up volume for audio)

Recommended Citation

Johnson, MD, MHS, Cheilonda, "The MUC5B Promoter Variant and Autoimmune Associated Interstitial Lung Disease" (2014). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 110.
https://jdc.jefferson.edu/pulmcritcaregrandrounds/110